At a glance: PANS — Pediatric Acute-onset Neuropsychiatric Syndrome — is a clinical condition defined by sudden, dramatic onset of OCD, anxiety, and related symptoms in children. Unlike PANDAS, which is specifically linked to Group A strep infections, PANS can be triggered by a wide range of infectious and non-infectious causes. A child who tests negative for strep may still have PANS triggered by something else entirely.
One of the most important distinctions in this entire field — and one that families frequently don't learn until they have already spent months chasing a strep connection that was never there — is the difference between PANDAS and PANS.
PANDAS is the more familiar name. It has been in the public conversation longer, and when parents first start searching for answers about sudden behavioral changes in their child, PANDAS is usually the term they encounter first. But PANDAS is actually the narrower of the two diagnoses. It describes a specific subset: children whose neuropsychiatric symptoms are triggered by Group A strep.
PANS is the broader category. It includes PANDAS, but it also includes every other child whose sudden-onset OCD and related symptoms were set off by something other than strep — or by a trigger that was never clearly identified at all. Understanding this distinction can reopen a diagnostic door that may have felt closed after a negative strep test.
PANDAS — Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections — requires a documented connection between symptom onset and a Group A strep infection. That connection is part of the definition. Without evidence of strep involvement, a child does not meet the criteria for PANDAS specifically.
PANS casts a wider net. The PANS definition requires sudden onset of OCD or severely restricted food intake, accompanied by at least two of a defined set of additional symptoms — anxiety, emotional lability, behavioral regression, sensory or motor abnormalities, deterioration in school performance, sleep disturbance, or urinary symptoms. It does not require a specific triggering organism. The trigger can be bacterial, viral, environmental, or in some cases never identified despite thorough evaluation.
This matters enormously for families who have been told their child doesn't have PANDAS because strep wasn't found. That may be true. But it leaves open a much larger question: whether PANS, triggered by something other than strep, is the more accurate frame for what is happening.
💡 Think of it this way: PANDAS is one specific road that leads to a particular destination. PANS is the name for the destination itself — the sudden neuropsychiatric presentation — however a child arrived there. Ruling out one road doesn't mean the destination isn't real.
The research and clinical literature on PANS has identified a range of infectious triggers that have been associated with sudden neuropsychiatric symptom onset in children. This list continues to evolve as more is understood about the condition.
📊 Infectious triggers associated with PANS onset in the clinical literature:
It is worth noting that in some children, no specific infectious trigger is ever clearly identified even after thorough evaluation. That does not mean PANS is not the right diagnosis. The clinical picture — the sudden onset, the symptom cluster, the absence of a prior psychiatric history — can still support the diagnosis even when the trigger remains unknown.
💬 If this framework is clicking for you and you're tired of piecing things together from random posts and forums, consider joining the Spectrum Care Hub Learning Community. You'll get full access to step-by-step biomedical coursework, printable tools, and new lessons added every month. Click here for details
Identifying the specific trigger, when possible, is clinically useful because it guides the treatment approach. A child whose PANS was triggered by Mycoplasma pneumoniae may respond to antibiotics that target that specific organism. A child whose symptoms followed a Lyme infection may need a different treatment framework entirely. A child with no identified trigger focuses treatment on the immune response itself rather than on clearing an active infection.
But the absence of a confirmed trigger does not mean treatment cannot begin or that the diagnosis is invalid. Experienced PANS providers work with incomplete information regularly — because the nature of these conditions means that by the time a family reaches a knowledgeable provider, the triggering infection may have long since resolved, leaving only the immune response behind.
What matters most from a treatment standpoint is understanding that an immune process is driving the neuropsychiatric symptoms — and addressing both the inflammation and the downstream behavioral and emotional effects of that inflammation, regardless of what set it off.
If your child had a negative strep test and the conversation stopped there, it may be worth revisiting — not to relitigate the strep question, but to ask a broader one. Was there any illness in the six to eight weeks before symptoms appeared? A respiratory infection that seemed minor? A period of unusual fatigue? Any tick exposure, travel, or environmental change?
Bringing that kind of detailed history to a provider experienced in PANS — rather than only PANDAS — opens a wider diagnostic conversation. A thorough PANS evaluation looks at a range of potential triggers, not strep alone, and interprets those findings within the full clinical picture.
It is also worth knowing that in some children, PANS and PANDAS co-exist with a history of multiple triggers over time. A child may have had a first episode triggered by strep and a subsequent episode triggered by a different infection. This is not uncommon, and it underscores why the broader PANS framework is often more clinically useful than focusing exclusively on the strep connection.
The PANDAS Physicians Network at pandasppn.org/practitioners and the PANS Network at pansnetwork.org both maintain directories of providers experienced in evaluating the full range of PANS triggers, not strep alone.
My child's symptoms came on suddenly but every infection test came back negative. Can it still be PANS? Yes. In some children with PANS, no specific triggering organism is ever identified even with thorough testing. The diagnosis is based on the clinical picture — the sudden onset, the specific symptom cluster, and the absence of another explanation — not on a confirmed positive test for a specific pathogen. A provider experienced in PANS will know how to evaluate and proceed when testing has not been informative.
How is Mycoplasma pneumoniae tested for, and is it commonly checked in PANS evaluations? Mycoplasma pneumoniae is typically tested through blood antibody testing — IgM and IgG titers — or through a PCR test on a respiratory swab during active illness. It is not always included in standard pediatric infectious workups, which is one reason it gets missed. Providers experienced in PANS know to include it when evaluating for potential triggers.
Could Lyme disease be the trigger for my child's PANS symptoms? It is possible, and this overlap is discussed with increasing frequency in PANS clinical conversations. Lyme disease can affect the central nervous system and produce psychiatric and behavioral symptoms that overlap with PANS. Standard Lyme testing has well-documented limitations, particularly early in infection, and a negative standard test does not definitively rule it out. This is an area where seeking a provider familiar with both PANS and tick-borne illness is particularly important.
If no trigger is ever found, does that mean my child won't respond to treatment? Not necessarily. Treatment for PANS when no trigger is identified focuses on addressing the immune dysregulation and neuroinflammation driving the symptoms, and on managing the neuropsychiatric symptoms through behavioral therapy alongside medical support. Many children improve with this approach even when the original trigger was never clearly identified.
Is COVID-19 a recognized PANS trigger? Post-COVID inflammatory processes have been associated with neuropsychiatric symptoms in some children, and this is an active area of clinical discussion and emerging research. The picture is still developing, but providers experienced in PANS are paying close attention to children whose symptom onset followed a COVID infection, particularly those who experienced MIS-C or prolonged post-COVID symptoms.
💬 If this helped you see your child's behavior and biology in a new light, the next step is to keep building on that clarity. Our Spectrum Care Hub subscription gives you the complete course library, deeper dive modules, and ongoing support, so you don't have to navigate autism and PANS/PANDAS care alone. Click here for details
Last reviewed by Mary Margaret Burch, FNP-BC — March 2026 © 2026 Spectrum Care Hub LLC / SpectrumCareHub.com. This article is for educational purposes only. Nothing here constitutes medical advice or creates a provider-patient relationship. Always work with a qualified, licensed healthcare provider before making any medical decisions for your child.